Veeva Systems EBITDA Margin 2013-2025 | VEEV
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Veeva Systems (VEEV) over the last 10 years. The current EBITDA margin for Veeva Systems as of October 31, 2025 is .
| Veeva Systems EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-10-31 | $3.08B | $0.90B | 29.32% |
| 2025-07-31 | $2.97B | $0.84B | 28.30% |
| 2025-04-30 | $2.86B | $0.81B | 28.20% |
| 2025-01-31 | $2.75B | $0.72B | 26.26% |
| 2024-10-31 | $2.66B | $0.67B | 25.04% |
| 2024-07-31 | $2.57B | $0.61B | 23.62% |
| 2024-04-30 | $2.49B | $0.54B | 21.86% |
| 2024-01-31 | $2.36B | $0.45B | 19.20% |
| 2023-10-31 | $2.30B | $0.43B | 18.77% |
| 2023-07-31 | $2.23B | $0.43B | 19.32% |
| 2023-04-30 | $2.18B | $0.44B | 20.05% |
| 2023-01-31 | $2.15B | $0.51B | 23.54% |
| 2022-10-31 | $2.08B | $0.52B | 25.19% |
| 2022-07-31 | $2.00B | $0.54B | 26.95% |
| 2022-04-30 | $1.92B | $0.57B | 29.40% |
| 2022-01-31 | $1.85B | $0.57B | 30.58% |
| 2021-10-31 | $1.76B | $0.54B | 30.80% |
| 2021-07-31 | $1.67B | $0.51B | 30.63% |
| 2021-04-30 | $1.56B | $0.47B | 30.26% |
| 2021-01-31 | $1.47B | $0.43B | 29.33% |
| 2020-10-31 | $1.38B | $0.39B | 28.39% |
| 2020-07-31 | $1.28B | $0.37B | 28.50% |
| 2020-04-30 | $1.20B | $0.34B | 28.74% |
| 2020-01-31 | $1.11B | $0.32B | 29.23% |
| 2019-10-31 | $1.03B | $0.32B | 31.12% |
| 2019-07-31 | $0.97B | $0.30B | 30.96% |
| 2019-04-30 | $0.91B | $0.28B | 30.70% |
| 2019-01-31 | $0.86B | $0.25B | 29.32% |
| 2018-10-31 | $0.82B | $0.23B | 28.15% |
| 2018-07-31 | $0.77B | $0.21B | 27.44% |
| 2018-04-30 | $0.73B | $0.20B | 26.96% |
| 2018-01-31 | $0.69B | $0.19B | 27.64% |
| 2017-10-31 | $0.66B | $0.21B | 31.27% |
| 2017-07-31 | $0.63B | $0.19B | 30.89% |
| 2017-04-30 | $0.59B | $0.18B | 29.78% |
| 2017-01-31 | $0.55B | $0.15B | 27.40% |
| 2016-10-31 | $0.51B | $0.11B | 21.06% |
| 2016-07-31 | $0.47B | $0.09B | 19.49% |
| 2016-04-30 | $0.44B | $0.09B | 20.05% |
| 2016-01-31 | $0.41B | $0.09B | 21.76% |
| 2015-10-31 | $0.38B | $0.09B | 24.35% |
| 2015-07-31 | $0.36B | $0.09B | 25.63% |
| 2015-04-30 | $0.34B | $0.09B | 25.52% |
| 2015-01-31 | $0.31B | $0.08B | 24.52% |
| 2014-10-31 | $0.29B | $0.07B | 22.76% |
| 2014-07-31 | $0.26B | $0.06B | 21.07% |
| 2014-04-30 | $0.24B | $0.05B | 20.00% |
| 2014-01-31 | $0.21B | $0.04B | 19.91% |
| 2013-07-31 | $0.13B | $0.03B | 21.71% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $28.621B | $2.747B |
| Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company's product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $9.242B | 0.00 |
| Doximity (DOCS) | United States | $4.711B | 20.02 |
| IRhythm Holdings (IRTC) | United States | $4.646B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $3.711B | 30.19 |
| Hinge Health (HNGE) | United States | $3.065B | 0.00 |
| Privia Health (PRVA) | United States | $2.754B | 172.23 |
| 10x Genomics (TXG) | United States | $2.293B | 0.00 |
| Heartflow (HTFL) | United States | $1.759B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $1.736B | 23.16 |
| Omnicell (OMCL) | United States | $1.638B | 45.62 |
| Azenta (AZTA) | United States | $1.318B | 53.00 |
| Enovis (ENOV) | United States | $1.245B | 6.54 |
| Clover Health Investments (CLOV) | United States | $1.044B | 0.00 |
| Schrodinger (SDGR) | United States | $0.840B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.768B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.724B | 0.00 |
| Phreesia (PHR) | United States | $0.720B | 0.00 |
| Talkspace (TALK) | United States | $0.625B | 125.67 |
| Standard BioTools (LAB) | United States | $0.431B | 0.00 |
| Claritev (CTEV) | United States | $0.380B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.338B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.320B | 0.00 |
| Evolent Health (EVH) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.307B | 0.00 |
| TruBridge (TBRG) | United States | $0.293B | 13.45 |
| Carlsmed (CARL) | United States | $0.291B | 0.00 |
| CapsoVision (CV) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.216B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.161B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.160B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.151B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.130B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 5.40 |
| American Well (AMWL) | United States | $0.088B | 0.00 |
| 111 (YI) | China | $0.070B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.064B | 0.00 |
| Outset Medical (OM) | United States | $0.062B | 0.00 |
| Pulmonx (LUNG) | United States | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Precipio (PRPO) | United States | $0.041B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.032B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.028B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.017B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.015B | 0.00 |
| Movano (MOVE) | United States | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.007B | 0.00 |
| Zhongchao (ZCMD) | China | $0.005B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.005B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |